UNRESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for UNRESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new UNRESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for UNRESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink untreatable liver tumors
Disease control Not yet recruitingThis study tests a new treatment for people with advanced liver cancer that cannot be removed by surgery. The treatment combines a type of internal radiation (Y-90) with three drugs that help the immune system fight cancer and block tumor growth. The goal is to see if this combin…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated May 26, 2026 07:04 UTC
-
New radiation approach targets liver tumors without surgery
Disease control Not yet recruitingThis study tests a radiation treatment called Yttrium-90 for people with liver cancer that cannot be surgically removed. About 64 adults with one or two small tumors will receive this treatment through a tiny tube into the liver's blood vessels. The goal is to see how well it shr…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
New combo attack shrinks untreatable liver tumors
Disease control Not yet recruitingThis study tests a powerful mix of treatments for people with liver cancer that cannot be surgically removed. It combines two types of local therapy (TACE and SBRT) with an immunotherapy drug and a targeted pill (donafenib). The goal is to see if this combination can shrink tumor…
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
Lab-Grown mini tumors could pick the right drug for liver cancer patients
Disease control Not yet recruitingThis study tests whether growing a patient's liver cancer cells in a lab and testing different drugs on them can help doctors choose the most effective treatment. About 94 adults with advanced liver cancer that cannot be removed by surgery will either receive standard therapy or …
Matched conditions: UNRESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE2 • Sponsor: Eastern Hepatobiliary Surgery Hospital • Aim: Disease control
Last updated May 07, 2026 18:41 UTC